India talks tough to end trade margins row as drug shortages loom
This article was originally published in SRA
Executive Summary
Faced with the prospect of continued disruptions to shipments of essential medicines in India from a disagreement over trade margins, the country's department of pharmaceuticals (DoP) has taken a tough stance, urging state governments to ensure smooth supplies, including by invoking the Essential Commodities Act if necessary.